🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
Current data on the impact of donor CHIP on long-term recipient outcome rem...
Status
Recruiting
Location
The University of Hong Kong
Start Date
2021-01-01
Trial ID
NCT04689750
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
The objective of this research is to measure certain indicators of resilien...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-09-28
Trial ID
NCT04188678
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and melpha...
Status
Terminated
Location
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Start Date
2005-07
Trial ID
NCT00121186
RATIONALE: A peripheral stem cell, bone marrow, or umbilical cord blood tra...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Start Date
2005-04
Trial ID
NCT00112645
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg an...
Status
Completed
Location
UF Health Shands Children's Hospital
Start Date
2018-06-15
Trial ID
NCT03513328
Treatments Being Tested
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested